Summary of WHO infection prevention and control guideline for Ebola and Marburg disease: a call for evidence based practice
BMJ
.
2024 Feb 26:384:2811.
doi: 10.1136/bmj.p2811.
Authors
Victoria Willet
1
,
Devika Dixit
1
2
,
Dale Fisher
3
,
Daniel G Bausch
4
5
,
Folasade Ogunsola
6
,
Joanne Khabsa
7
,
Elie A Akl
8
9
,
April Baller
1
;
Guideline Development Group
Collaborators
Guideline Development Group
:
Maya Chávez
,
May Chu
,
Nizam Damani
,
Claire Dorion
,
Gwen Eamer
,
Robert Fowler
,
Joost Hopman
,
Emilio Hornsey
,
Richard Kojan
,
Daniele Lantagne
,
Gillian McKay
,
Shaheen Mehtar
,
Mercy Njeru
,
Tochi Okwor
,
Sorie Samura
,
Sridhar Venkatapuram
,
Katie Wilson
Affiliations
1
World Health Organization, Geneva, Switzerland.
2
Cumming School of Medicine, University of Calgary, Alberta, Canada.
3
Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
4
FIND, Geneva, Switzerland.
5
London School of Hygiene and Tropical Medicine, London, UK.
6
College of Medicine, University of Lagos, Nigeria.
7
Clinical Research Institute, American University of Beirut, Beirut, Lebanon.
8
Department of Internal Medicine, American University of Beirut, Lebanon.
9
Department of Health Research Methods, Evidence, and Impact, McMaster University, Ontario, Canada.
PMID:
38408787
PMCID:
PMC10897755
DOI:
10.1136/bmj.p2811
No abstract available
MeSH terms
Animals
Ebolavirus*
Evidence-Based Practice
Hemorrhagic Fever, Ebola* / epidemiology
Hemorrhagic Fever, Ebola* / prevention & control
Humans
Marburg Virus Disease* / prevention & control
World Health Organization
Grants and funding
001/WHO_/World Health Organization/International